Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]
Al-Khatib, SM +15 more
core +1 more source
A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications. [PDF]
McCarville B, Osborn J.
europepmc +1 more source
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry [PDF]
Jan Beyer‐Westendorf +12 more
openalex +1 more source
Left Ventricular Pseudoaneurysm Possibly Associated with Rivaroxaban Therapy Disappeared after Cessation of Rivaroxaban: Case Report and Literature Review. [PDF]
Kiryu K +7 more
europepmc +1 more source
Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study. [PDF]
Sun J, Mehta HB, Segal JB, Alexander GC.
europepmc +1 more source
Two-week administration of rivaroxaban resolved left atrial thrombus [PDF]
Toru Kato +5 more
openalex +1 more source
In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments. [PDF]
Du W, Liu Z, Li Y, Wang Z, Dong Z.
europepmc +1 more source
Venous Thromboembolism Due to Suspected Interaction Between Nevirapine and Rivaroxaban
Duane Bates +3 more
openalex +2 more sources
Application of Stability Indicating HPLC Method with UV Detector to the Analysis of Rivaroxaban in Bulk and Tablet Dosage Form [PDF]
Burla Sunitha +4 more
openalex +1 more source
Effect of Gene Polymorphism on the Pharmacokinetics and Clinical Outcomes of Rivaroxaban: State-of-the-Art Review. [PDF]
Wang L, Chen G, Hu W, Chen J, He Y.
europepmc +1 more source

